Prescribing patterns and healthcare costs of gout

Yi Yun Lee, Li Na Kuo, Jin Hua Chen, Yi Chun Lin, Lung Fang Chen, Yu Ko

Research output: Contribution to journalArticle

Abstract

Objective/methods: The Longitudinal Health Insurance Database (LHID) 2010 was used to identify gout cases and their number of gout flares. Results: Out of 21,376 gout patients, a total of 3561 (16.7%) had frequent gout flares (≥3 gout flares/year). Average all-cause healthcare utilization (35.9 visits vs. 30.7 visits; p <.001) and gout-related utilization (22.7 visits vs. 15.6 visits; p <.001) were higher in frequent gout flare patients than in those with infrequent gout flares. The median gout-related cost (USD $369 vs. $285; p <.001), but not all-cause costs (p =.25), were higher in frequent gout flare patients compared to the infrequent group. Over 55.8% of the flares were treated with colchicine + NSAIDs. Conclusions: In conclusion, patients with frequent gout flares had higher healthcare utilization and gout-related healthcare costs. Colchicine + NSAIDs are commonly used therapy for gout flare.

Original languageEnglish
JournalCurrent Medical Research and Opinion
DOIs
Publication statusAccepted/In press - Jan 1 2019

Fingerprint

Gout
Health Care Costs
Colchicine
Non-Steroidal Anti-Inflammatory Agents
Delivery of Health Care
Costs and Cost Analysis
Health Insurance

Keywords

  • costs
  • Gout
  • prescribing patterns
  • Taiwan

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Prescribing patterns and healthcare costs of gout. / Lee, Yi Yun; Kuo, Li Na; Chen, Jin Hua; Lin, Yi Chun; Chen, Lung Fang; Ko, Yu.

In: Current Medical Research and Opinion, 01.01.2019.

Research output: Contribution to journalArticle

Lee, Yi Yun ; Kuo, Li Na ; Chen, Jin Hua ; Lin, Yi Chun ; Chen, Lung Fang ; Ko, Yu. / Prescribing patterns and healthcare costs of gout. In: Current Medical Research and Opinion. 2019.
@article{7634edad8b7e491aa731ef693f83234a,
title = "Prescribing patterns and healthcare costs of gout",
abstract = "Objective/methods: The Longitudinal Health Insurance Database (LHID) 2010 was used to identify gout cases and their number of gout flares. Results: Out of 21,376 gout patients, a total of 3561 (16.7{\%}) had frequent gout flares (≥3 gout flares/year). Average all-cause healthcare utilization (35.9 visits vs. 30.7 visits; p <.001) and gout-related utilization (22.7 visits vs. 15.6 visits; p <.001) were higher in frequent gout flare patients than in those with infrequent gout flares. The median gout-related cost (USD $369 vs. $285; p <.001), but not all-cause costs (p =.25), were higher in frequent gout flare patients compared to the infrequent group. Over 55.8{\%} of the flares were treated with colchicine + NSAIDs. Conclusions: In conclusion, patients with frequent gout flares had higher healthcare utilization and gout-related healthcare costs. Colchicine + NSAIDs are commonly used therapy for gout flare.",
keywords = "costs, Gout, prescribing patterns, Taiwan",
author = "Lee, {Yi Yun} and Kuo, {Li Na} and Chen, {Jin Hua} and Lin, {Yi Chun} and Chen, {Lung Fang} and Yu Ko",
year = "2019",
month = "1",
day = "1",
doi = "10.1080/03007995.2018.1552577",
language = "English",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Informa Healthcare",

}

TY - JOUR

T1 - Prescribing patterns and healthcare costs of gout

AU - Lee, Yi Yun

AU - Kuo, Li Na

AU - Chen, Jin Hua

AU - Lin, Yi Chun

AU - Chen, Lung Fang

AU - Ko, Yu

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Objective/methods: The Longitudinal Health Insurance Database (LHID) 2010 was used to identify gout cases and their number of gout flares. Results: Out of 21,376 gout patients, a total of 3561 (16.7%) had frequent gout flares (≥3 gout flares/year). Average all-cause healthcare utilization (35.9 visits vs. 30.7 visits; p <.001) and gout-related utilization (22.7 visits vs. 15.6 visits; p <.001) were higher in frequent gout flare patients than in those with infrequent gout flares. The median gout-related cost (USD $369 vs. $285; p <.001), but not all-cause costs (p =.25), were higher in frequent gout flare patients compared to the infrequent group. Over 55.8% of the flares were treated with colchicine + NSAIDs. Conclusions: In conclusion, patients with frequent gout flares had higher healthcare utilization and gout-related healthcare costs. Colchicine + NSAIDs are commonly used therapy for gout flare.

AB - Objective/methods: The Longitudinal Health Insurance Database (LHID) 2010 was used to identify gout cases and their number of gout flares. Results: Out of 21,376 gout patients, a total of 3561 (16.7%) had frequent gout flares (≥3 gout flares/year). Average all-cause healthcare utilization (35.9 visits vs. 30.7 visits; p <.001) and gout-related utilization (22.7 visits vs. 15.6 visits; p <.001) were higher in frequent gout flare patients than in those with infrequent gout flares. The median gout-related cost (USD $369 vs. $285; p <.001), but not all-cause costs (p =.25), were higher in frequent gout flare patients compared to the infrequent group. Over 55.8% of the flares were treated with colchicine + NSAIDs. Conclusions: In conclusion, patients with frequent gout flares had higher healthcare utilization and gout-related healthcare costs. Colchicine + NSAIDs are commonly used therapy for gout flare.

KW - costs

KW - Gout

KW - prescribing patterns

KW - Taiwan

UR - http://www.scopus.com/inward/record.url?scp=85059699441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059699441&partnerID=8YFLogxK

U2 - 10.1080/03007995.2018.1552577

DO - 10.1080/03007995.2018.1552577

M3 - Article

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

ER -